Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

[Guideline-conform exact diagnosis and coding of dementia].

Hofmann W, Wille E, Kaminsky S.

Z Gerontol Geriatr. 2019 Mar;52(2):179-194. doi: 10.1007/s00391-019-01509-3. Epub 2019 Mar 4. Review. German.

PMID:
30830315
2.

Gender Stereotypes in a Children's Television Program: Effects on Girls' and Boys' Stereotype Endorsement, Math Performance, Motivational Dispositions, and Attitudes.

Wille E, Gaspard H, Trautwein U, Oschatz K, Scheiter K, Nagengast B.

Front Psychol. 2018 Dec 4;9:2435. doi: 10.3389/fpsyg.2018.02435. eCollection 2018.

3.

Decision making guidelines for mining historic landfill sites in Flanders.

Winterstetter A, Wille E, Nagels P, Fellner J.

Waste Manag. 2018 Jul;77:225-237. doi: 10.1016/j.wasman.2018.03.049. Epub 2018 May 15.

PMID:
29685606
4.

[Uniform remuneration in the dual health insurance system?]

Hess R, Thüsing G, Ulrich V, Wille E, Wollenschläger F.

Urologe A. 2018 Mar;57(3):269-271. doi: 10.1007/s00120-018-0616-4. German. No abstract available.

PMID:
29520418
5.

The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer.

Silwal-Pandit L, Nord S, von der Lippe Gythfeldt H, Møller EK, Fleischer T, Rødland E, Krohn M, Borgen E, Garred Ø, Olsen T, Vu P, Skjerven H, Fangberget A, Holmen MM, Schlitchting E, Wille E, Nordberg Stokke M, Moen Vollan HK, Kristensen V, Langerød A, Lundgren S, Wist E, Naume B, Lingjærde OC, Børresen-Dale AL, Engebraaten O.

Clin Cancer Res. 2017 Aug 15;23(16):4662-4670. doi: 10.1158/1078-0432.CCR-17-0160. Epub 2017 May 9.

6.

Fatigue During and After Breast Cancer Therapy-A Prospective Study.

Reinertsen KV, Engebraaten O, Loge JH, Cvancarova M, Naume B, Wist E, Edvardsen H, Wille E, Bjøro T, Kiserud CE.

J Pain Symptom Manage. 2017 Mar;53(3):551-560. doi: 10.1016/j.jpainsymman.2016.09.011. Epub 2016 Dec 29.

PMID:
28042070
7.

The Nozoe Autograph Books: why sign them? Why publish them? Why read them? Why treasure them? Personal and professional reflections.

Wille EE.

Chem Rec. 2014 Apr;14(2):334-57. doi: 10.1002/tcr.201400006. Epub 2014 Mar 24. No abstract available.

PMID:
24664862
8.

Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease.

Johri A, Calingasan NY, Hennessey TM, Sharma A, Yang L, Wille E, Chandra A, Beal MF.

Hum Mol Genet. 2012 Mar 1;21(5):1124-37. doi: 10.1093/hmg/ddr541. Epub 2011 Nov 17.

9.

Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.

Dumont M, Kipiani K, Yu F, Wille E, Katz M, Calingasan NY, Gouras GK, Lin MT, Beal MF.

J Alzheimers Dis. 2011;27(1):211-23. doi: 10.3233/JAD-2011-110209.

10.

Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease.

Thomas B, Banerjee R, Starkova NN, Zhang SF, Calingasan NY, Yang L, Wille E, Lorenzo BJ, Ho DJ, Beal MF, Starkov A.

Antioxid Redox Signal. 2012 May 1;16(9):855-68. doi: 10.1089/ars.2010.3849. Epub 2011 Jun 16.

11.

Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis.

Neymotin A, Calingasan NY, Wille E, Naseri N, Petri S, Damiano M, Liby KT, Risingsong R, Sporn M, Beal MF, Kiaei M.

Free Radic Biol Med. 2011 Jul 1;51(1):88-96. doi: 10.1016/j.freeradbiomed.2011.03.027. Epub 2011 Mar 30.

12.

Apocynin administration does not improve behavioral and neuropathological deficits in a transgenic mouse model of Alzheimer's disease.

Dumont M, Stack C, Elipenhali C, Calingasan NY, Wille E, Beal MF.

Neurosci Lett. 2011 Apr 4;492(3):150-4. doi: 10.1016/j.neulet.2011.01.077. Epub 2011 Feb 12.

13.

Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease.

Ho DJ, Calingasan NY, Wille E, Dumont M, Beal MF.

Exp Neurol. 2010 Sep;225(1):74-84. doi: 10.1016/j.expneurol.2010.05.006. Epub 2010 Jun 1.

PMID:
20561979
14.

Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy.

Wille E, Scholze J, Alegria E, Ferri C, Langham S, Stevens W, Jeffries D, Uhl-Hochgraeber K.

Eur J Health Econ. 2011 Jun;12(3):205-18. doi: 10.1007/s10198-010-0223-9. Epub 2010 Apr 20.

PMID:
20405160
15.

Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease.

Stack C, Ho D, Wille E, Calingasan NY, Williams C, Liby K, Sporn M, Dumont M, Beal MF.

Free Radic Biol Med. 2010 Jul 15;49(2):147-58. doi: 10.1016/j.freeradbiomed.2010.03.017. Epub 2010 Mar 23.

16.

N-iminoethyl-L-lysine improves memory and reduces amyloid pathology in a transgenic mouse model of amyloid deposition.

Dumont M, Wille E, Calingasan NY, Nathan C, Flint Beal M, Lin MT.

Neurochem Int. 2010 Jan;56(2):345-51. doi: 10.1016/j.neuint.2009.11.006. Epub 2009 Nov 13.

PMID:
19914323
17.

Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis.

Neymotin A, Petri S, Calingasan NY, Wille E, Schafer P, Stewart C, Hensley K, Beal MF, Kiaei M.

Exp Neurol. 2009 Nov;220(1):191-7. doi: 10.1016/j.expneurol.2009.08.028. Epub 2009 Sep 4.

18.

Mice deficient in dihydrolipoyl succinyl transferase show increased vulnerability to mitochondrial toxins.

Yang L, Shi Q, Ho DJ, Starkov AA, Wille EJ, Xu H, Chen HL, Zhang S, Stack CM, Calingasan NY, Gibson GE, Beal MF.

Neurobiol Dis. 2009 Nov;36(2):320-30. doi: 10.1016/j.nbd.2009.07.023. Epub 2009 Aug 4.

19.

Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.

Yang L, Calingasan NY, Thomas B, Chaturvedi RK, Kiaei M, Wille EJ, Liby KT, Williams C, Royce D, Risingsong R, Musiek ES, Morrow JD, Sporn M, Beal MF.

PLoS One. 2009 Jun 1;4(6):e5757. doi: 10.1371/journal.pone.0005757.

20.

Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.

Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Beal MF.

J Neurochem. 2009 Jun;109(5):1427-39. doi: 10.1111/j.1471-4159.2009.06074.x. Epub 2009 Mar 28.

21.

Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease.

Dumont M, Wille E, Stack C, Calingasan NY, Beal MF, Lin MT.

FASEB J. 2009 Aug;23(8):2459-66. doi: 10.1096/fj.09-132928. Epub 2009 Apr 3.

22.

Triterpenoid CDDO-methylamide improves memory and decreases amyloid plaques in a transgenic mouse model of Alzheimer's disease.

Dumont M, Wille E, Calingasan NY, Tampellini D, Williams C, Gouras GK, Liby K, Sporn M, Nathan C, Flint Beal M, Lin MT.

J Neurochem. 2009 Apr;109(2):502-12. doi: 10.1111/j.1471-4159.2009.05970.x. Epub 2009 Feb 7. Erratum in: J Neurochem. 2009 May;109(4):1192.. Nathan, Carl [added].

23.

[Diagnostics of patients with syncope of unknown origin: indications for hospital admission and for in- and out-hospital services?].

Schuchert A, Wille E.

Herz. 2008 Sep;33(6):412-8. doi: 10.1007/s00059-008-3145-x. Review. German.

PMID:
19156376
24.

Influence of mitochondrial enzyme deficiency on adult neurogenesis in mouse models of neurodegenerative diseases.

Calingasan NY, Ho DJ, Wille EJ, Campagna MV, Ruan J, Dumont M, Yang L, Shi Q, Gibson GE, Beal MF.

Neuroscience. 2008 Jun 2;153(4):986-96. doi: 10.1016/j.neuroscience.2008.02.071. Epub 2008 Mar 18.

25.

Exploring an ultracold fermi-fermi mixture: interspecies feshbach resonances and scattering properties of 6Li and 40K.

Wille E, Spiegelhalder FM, Kerner G, Naik D, Trenkwalder A, Hendl G, Schreck F, Grimm R, Tiecke TG, Walraven JT, Kokkelmans SJ, Tiesinga E, Julienne PS.

Phys Rev Lett. 2008 Feb 8;100(5):053201. Epub 2008 Feb 5.

PMID:
18352370
26.

Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism.

Cleren C, Yang L, Lorenzo B, Calingasan NY, Schomer A, Sireci A, Wille EJ, Beal MF.

J Neurochem. 2008 Mar;104(6):1613-21. Epub 2007 Oct 31.

27.

The lipophilic metal chelators DP-109 and DP-460 are neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.

Petri S, Calingasan NY, Alsaied OA, Wille E, Kiaei M, Friedman JE, Baranova O, Chavez JC, Beal MF.

J Neurochem. 2007 Aug;102(3):991-1000.

28.

Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis.

Kiaei M, Kipiani K, Calingasan NY, Wille E, Chen J, Heissig B, Rafii S, Lorenzl S, Beal MF.

Exp Neurol. 2007 May;205(1):74-81. Epub 2007 Feb 12.

PMID:
17362932
29.

Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice.

Petri S, Kiaei M, Wille E, Calingasan NY, Flint Beal M.

J Neurol Sci. 2006 Dec 21;251(1-2):44-9. Epub 2006 Oct 17.

PMID:
17049562
30.

Cell-permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis.

Petri S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, Calingasan NY, Szeto HH, Beal MF.

J Neurochem. 2006 Aug;98(4):1141-8.

31.

Synchronization of delay-coupled oscillators: a study of semiconductor lasers.

Wünsche HJ, Bauer S, Kreissl J, Ushakov O, Korneyev N, Henneberger F, Wille E, Erzgräber H, Peil M, Elsässer W, Fischer I.

Phys Rev Lett. 2005 Apr 29;94(16):163901. Epub 2005 Apr 26.

PMID:
15904226
32.

Healthcare reform and expenditure on drugs. The German situation.

Ulrich V, Wille E.

Pharmacoeconomics. 1996;10 Suppl 2:81-8.

PMID:
10163440
33.

[Clinical relevance of immunoglobulin M antibody fraction against hepatitis B core antigen (anti-HBc-IgM) (author's transl)].

Feuerhake A, Wille E, Müller R.

Dtsch Med Wochenschr. 1982 Jul 2;107(26):1012-4. German.

PMID:
7084068
34.

[Tuberculosis lymphadenitis submandibular. Clinical case (author's transl)].

Madeira AA, Wille ER.

Rev Catarinense Odontol. 1976 Jul-Dec;3(2):8-12. Portuguese. No abstract available.

PMID:
1077193
35.

[Effectivity of anticoagulation and extension of long-term anticoagulant therapy].

Wille E.

Z Allgemeinmed. 1974 Nov 30;50(33):1521-5. German. No abstract available.

PMID:
4218413
36.

[Changes in isometric contraction during the relaxation period following rapid extension].

Gülch R, Maisch B, Wille E, Jacob R.

Pflugers Arch. 1972;332:Suppl 332:R35. German. No abstract available.

PMID:
5066009
37.

[Inhibition of neural acetylcholine release in the human ventricle myocardium by graduated tetrodotoxin poisoning].

Sieber G, Wille E, Kissling G.

Pflugers Arch. 1972;332:Suppl 322:R44. German. No abstract available.

PMID:
4340709
38.

[Effects of prolonged glucuronic acid lactone on tissue hyaluronidase activity].

HOLLMANN S, WILLE E.

Z Rheumaforsch. 1954 Aug;13(7-8):202-5. German. No abstract available.

PMID:
13206232
39.

[The metabolism of glucuronic acid in the animal organism. I. The elimination of glucuronic acid under normal conditions and after application of lacton of glucuronic acid].

HOLLMANN S, WILLE E.

Hoppe Seylers Z Physiol Chem. 1952;290(3-6):91-106. Undetermined Language. No abstract available.

PMID:
12989939
40.

Ueber Sexualreflexe beim Rind und ihre Beeinflussung durch Umweltbedingungen; Stallhaltung, Futterung, Paarung.

WILLE E.

Tierarztl Umsch. 1948 Jun;3(11-12):173-7. Undetermined Language. No abstract available.

PMID:
18867346

Supplemental Content

Support Center